Birdwatch Note
2024-08-02 05:20:58 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Imane Khelif non è transgender. L'atleta soffre dalla nascita di iperandrogenismo con conseguente maggiort produzione di testosterone. https://www.rte.ie/news/primetime/2024/0731/1462837-explained-the-gender-controversy-miring-womens-olympic-boxing/
Written by 32EA1AE44A8BFD182963F52E466D264F28D2030D06D022B9AFB003B5D16074BD
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1818983335672111125
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1819241964501361135
- noteId - 1819241964501361135
- participantId -
- noteAuthorParticipantId - 32EA1AE44A8BFD182963F52E466D264F28D2030D06D022B9AFB003B5D16074BD Participant Details
- createdAtMillis - 1722576058876
- tweetId - 1818983335672111125
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 1
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Imane Khelif non è transgender. L'atleta soffre dalla nascita di iperandrogenismo con conseguente maggiort produzione di testosterone. https://www.rte.ie/news/primetime/2024/0731/1462837-explained-the-gender-controversy-miring-womens-olympic-boxing/
Note Ratings
| rated at | rated by | |
| 2024-08-03 11:03:46 -0500 | Rating Details | |
| 2024-08-03 10:13:19 -0500 | Rating Details | |
| 2024-08-02 14:47:50 -0500 | Rating Details | |
| 2024-08-02 03:55:48 -0500 | Rating Details | |
| 2024-08-02 03:26:17 -0500 | Rating Details | |
| 2024-08-02 03:22:26 -0500 | Rating Details | |
| 2024-08-02 03:04:43 -0500 | Rating Details | |
| 2024-08-02 02:59:46 -0500 | Rating Details | |
| 2024-08-02 02:48:20 -0500 | Rating Details | |
| 2024-08-02 02:34:02 -0500 | Rating Details | |
| 2024-08-02 02:03:42 -0500 | Rating Details | |
| 2024-08-02 01:57:19 -0500 | Rating Details | |
| 2024-08-02 01:40:42 -0500 | Rating Details | |
| 2024-08-02 01:23:08 -0500 | Rating Details | |
| 2024-08-02 00:31:48 -0500 | Rating Details | |
| 2024-08-03 14:51:03 -0500 | Rating Details | |
| 2024-08-02 04:45:33 -0500 | Rating Details | |
| 2024-08-02 03:20:06 -0500 | Rating Details | |
| 2024-08-02 01:50:10 -0500 | Rating Details | |
| 2024-08-02 01:46:02 -0500 | Rating Details | |
| 2024-08-02 01:03:02 -0500 | Rating Details |